Whitman, Eric D.
Totev, Todor I.
Jiang, Shan
da Costa, Wilson L. Jr.
Grebennik, Dmitri
Wang, Hongjue
Boca, Andra-Ecaterina
Ayyagari, Rajeev
Article History
Received: 22 December 2023
Accepted: 24 March 2024
First Online: 27 March 2024
Declarations
:
: This study was granted exempt status by WCG IRB on Nov 29, 2022.
: Not applicable.
: Eric D. Whitman has provided consulting services to Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA and is a member of the speakers bureaus for Merck & Co., Inc., Rahway, NJ, USA, Bristol-Myers Squibb, and Regeneron. Todor I. Totev, Wilson L. da Costa Jr., Hongjue Wang, Andra-Ecaterina Boca, and Rajeev Ayyagari are employees of Analysis Group, Inc., which provided consulting services to Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA for the conduct of this study. Shan Jiang and Dmitri Grebennik are employees of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA, which sponsored this study.